(Q46002812)

English

In vitro-in vivo relationship of oral extended-release dosage forms.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

In vitro-in vivo relationship of oral extended-release dosage forms. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

author name string

F Y Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

N C Sambol

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

R P Giannini

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

C Y Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

13

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

1501-1506

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro-in vivo correlation of a modified-release oral form of ketotifen: in vitro dissolution rate specification.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo/in vitro correlation of experimental sustained-release theophylline formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro-in vivo correlation for modified-release formulations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of oral extended-release dosage forms. I. Release kinetics, concentration, and absorbed fraction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8899841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1016023428028

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8899841

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46002812&oldid=1389291277"